ABSTRACT
Salvia rosmarinus, formerly known as Rosmarinus officinalis, is a medicinal plant known as one of the sources of abietane‐type diterpenoids. The largest family of chemical constituents from the Salvia genus is abietanes and rearranged abietanes. Since 1976, 365 of the 545 known diterpenoids have been recognized as abietane diterpenoids. Carnosic acid, carnosol, rosmanol, epirosmanol, and their derivatives are among the bioactive abietanes that have gained much attention because of the wide spectrum of pharmacological activities. This review presents information on the distribution, isolation, biosynthesis, structural variation, degradation, semi‐synthetic strategies, pharmacokinetics, and bioactivities of abietane‐type diterpenoids from S. rosmarinus. Recent developments in eco‐friendly extraction techniques, namely, supercritical fluid extraction, microwave‐assisted extraction, ultrasound‐assisted extraction, and pressurized liquid extraction, are also described in this review. The biosynthetic pathway from geranylgeranyl diphosphate to main diterpenoids, such as carnosic acid and carnosol, is also presented. Moreover, newly isolated compounds, structure‐activity relationships, and antioxidant, antimicrobial, anti‐inflammatory, neuroprotective, and anticancer activities are included. Moreover, the pharmacokinetics of abietane diterpenoids isolated from S. rosmarinus and their medicinal applications are also covered in this review.
Keywords: abietane‐type diterpenoids, geranylgeranyl diphosphate, rosemary, Salvia, Salvia rosmarinus
The review delves into the findings on abietane diterpenes from Salvia rosmarinus. It comprises the phytochemistry, biological activities, biosynthesis, degradation studies, semisynthesis, and pharmacokinetic studies of these compounds. The potential of these compounds for future development has also been highlighted.

Abbreviations
- AKT
protein Kinase B
- ARE
antioxidant response element
- AST
aminotransferase
- AUC
area under the curve
- Bax
bcl‐2‐associated X protein
- Bcl‐2
β‐cell lymphoma‐2
- BHA
butylated hydroxyanisole
- BHT
butylated hydroxytoluene
- CA
carnosic acid
- CAT
catalase
- CDKs
cyclin‐dependent kinases
- Cmax
maximum plasma concentration
- COX
cyclooxygenase
- CPS
copalyl diphosphate synthase
- CS
carnosol
- DAD
UV‐diode array detector
- DMAPP
dimethylallyl diphosphate
- EMT
epithelial mesenchymal transition
- ER
endoplasmic reticulum
- ERK
extracellular signal regulated kinase
- FPP
farnesyl diphosphate
- FPS
farnesyl diphosphate synthase
- GGPP
geranylgeranyl diphosphate
- GGPS
geranylgeranyl diphosphate synthase
- GPP
geranyl diphosphate
- GPS
geranyl diphosphate synthase
- HIV
human immunodeficiency virus
- HO
1‐heme oxygenase‐1
- HPLC
high‐performance liquid chromatography
- IL
interleukin
- iNOS
inducible nitric oxide synthase
- IPP
isopentenyl pyrophosphate
- JAK
Janus kinase
- JNK‐c
Jun N‐terminal Kinase
- Keap1
Kelch‐like ECH‐associated protein 1
- LD50
median lethal dose
- MAE
microwave‐assisted extraction
- MAPKs
mitogen‐activated protein kinases
- Mdm2
mouse double minute 2
- MEP
methylerythritol Phosphate
- MIC
minimum inhibitory concentration
- MiS
miltiradiene synthase
- MMP
matrix metalloproteinases
- MS
mass spectrometry
- mTOR
mechanistic target of rapamycin (mTOR)
- NF‐κB
nuclear factor kappa‐light‐chain‐enhancer
- NMR
nuclear magnetic resonance
- NO
nitric oxide
- Nrf2
nuclear factor‐erythroid 2‐related factor 2
- PARP
poly(ADP‐ribose) polymerase
- PGE2
prostaglandin E2
- P‐gp
P‐glycoprotein
- PI3K
phosphoinositide 3‐kinase
- PLE
pressurized liquid extraction
- PMNL
polymorphonuclear leukocytes
- ROS
reactive oxygen species
- SFE
supercritical fluid extraction
- SOD
superoxide dismutase
- STAT
signal transducer and activator of transcription
- TIMPs
tissue inhibitors of metalloproteinases
- Tmax
time of maximum concentration
- TNF
tumour necrosis factor
- TOF
time of flight
- TTCCs
T‐type calcium channels
- UAE
ultrasound‐assisted extraction
- uPA
urokinase plasminogen activator
1. Introduction
Salvia is a member of the Lamiaceae family, which is the largest in the world, with over 220 genera and 4,000 species found almost everywhere. This genus contains 900 species worldwide [1]. Its major habitats are in East Asia, Southwest Asia, the Mediterranean, and Mesoamerica/South America [2]. Abietane‐type diterpenoids are a class of compounds found in numerous plant species, particularly in this genus. Abietanes are naturally occurring diterpenoids derived from terrestrial plants with diverse origins. The range of fascinating biological activity they exhibit piques the curiosity of the pharmaceutical and medicinal industries [3]. The name of the abietane diterpenoid comes from abietic acid, which is one of the resin acids found in coniferous oleoresin. Abietic acid was discovered and thoroughly studied in the early twentieth century and serves as the basic structure of the abietane class. Later, the name “abietane” was standardized based on abietic acid [4]. The review covers the phytochemistry, pharmacological potential, and prospects for the future with regard to abietane‐type diterpenoids found in Salvia rosmarinus. Abietane‐type diterpenoids (Figure 1) are among the numerous bioactive compounds occurring in the genus Salvia, which is also known as Sage.
FIGURE 1.

(A) Salvia rosmarinus plant. (B) Basic skeleton of abietane‐type diterpenes.
The diverse biological activities of abietane‐type diterpenoids in S. rosmarinus are due to the tricyclic diterpenoid skeleton. The most common abietane‐type diterpenoids found in S. rosmarinus are carnosic acid and carnosol. Rosmanol, occurring in S. rosmarinus, is also reported to exhibit antitumor as well as antiviral activity. Recently, six new abietane diterpenoids, rosmarinusin Q‐V (Figure 2), have also been reported from S. rosmarinus using phytochemical investigation. Out of these, rosmarinusin Q was a novel abietane diterpenoid containing a 6/6/5 skeleton, whose ring C was an α, β‐unsaturated five‐element ketone [5]. Spectroscopic techniques such as NMR and mass spectrometry are generally employed to determine the structure of these compounds. Abietanes and rearranged abietanes form the major group of Salvia plant constituents. It is the most abundant known group of Salvia diterpenoids, with 19 subgroups, and is seemingly the most distributed [6].
FIGURE 2.

Chemical structures of compounds Rosmarinusin Q‐V.
Rosemary contains trace levels of rosmanol, but its two main and pharmacologically significant diterpenes are carnosic acid (CA) and carnosol (CS). In particular, the dried rosemary leaves contain 4 g of carnosic acid and 0.4 g of carnosol per 100 g, respectively [7, 8]. However, it also depends upon the chemotype of the species. These substances are o‐diphenolic diterpenes having an abietane scaffold made up of a fused six‐membered tricyclic ring structure with an aromatic ring. Their glucuronide derivatives appeared in plasma as early as 25 min after oral administration in rats, suggesting their high bioavailability [9]. More specifically, the bioavailability of CA was approximately 40% after oral administration [10]. In vivo, three major processes are responsible for the breakdown of carnosic acid: oxidation, glucuronidation, and methylation [11]. Finally, carnosic acid was detected in rat brain tissue, which suggests that it crosses the blood–brain barrier. This provides a basis for several studies that have identified neuroprotective and cognitive benefits.
2. Methodology
Information about the chemical composition, pharmacology, and biological activities of S. rosmarinus was collected using the databases Scopus, Web of Science, Google Scholar, ScienceDirect, and PubMed. The following search terms were used: “abietane diterpenoids in Rosmarinus officinalis”, or “abietane diterpenoids in Salvia”, or “abietane diterpenoids”, or “abietane diterpenoids in S. rosmarinus”. A total of 1838 search results were obtained from these databases, and after screening and assessment of the results, 85 references were found suitable to include in the review (Figure 3).
FIGURE 3.

PRISMA flow diagram for the inclusion of the databases and registries in the review.
3. Inclusion and Exclusion Criteria
The search for this review was solely performed in the English language since 1965, reporting pharmacological and chemical data, and some experimental studies on animals, using the isolated compounds from S. rosmarinus. Finally, in order to ensure reliability, only publications in peer‐reviewed journals were chosen.
4. Historical Significance
Greeks and Romans used S. rosmarinus for medical purposes since 500 B.C. Even in 3000 B.C., Egyptian tombs included dried rosemary sprigs. Because of its pleasant scent, the ancient Egyptians valued rosemary. They used it in cosmetics, mummy preservation, and other rituals. In medieval Europe, people commonly used rosemary at weddings to symbolize loyalty and devotion. It also served to treat various ailments, including headaches, digestive issues, and breathing problems [12].
5. Morphological Distribution of Abietane‐Diterpenoids
In Salvia species, abietane‐type diterpenes are primarily found in the aerial portions (leaves, stems) rather than in rhizomes and roots. In numerous rosemary tissues, researchers examined the distribution of carnosic acid, 12‐O‐methyl carnosic acid, carnosol, rosmanol, and 11,12‐di‐O‐methyl isorosmanol. The relative levels of diterpenes were similar across the tissues analyzed. Carnosic acid was six times more concentrated than 12‐O‐methyl carnosic acid and carnosol, which were found in similar amounts. Rosmanol appeared in trace quantities, while isorosmanol showed a somewhat lower concentration than carnosol. The concentration of 11,12‐di‐O‐methyl isorosmanol was ten times less than that of isorosmanol. Diterpenes were not found in every tissue analyzed. Sepals had 3.2 times the diterpene level of petals, while leaves contained around 30% less. Trace amounts of diterpenes appeared in stems, and small amounts were present in seeds. Diterpenes were more abundant in the leaves compared to the roots. The oxidation product of carnosic acid, isorosmanol, undergoes O‐methylation within the chloroplasts. The resultant diterpene, 11,12‐di‐O‐methyl isorosmanol, is subsequently transferred by the chloroplasts to the rosemary's plasma membrane [13].
6. Extraction Methods of Abietane‐Diterpenoids
The extraction parameters, such as temperature, particle size, type of solvent, polarity, concentration, and acidity, all determine the efficiency of the extraction of various compounds of rosemary [14, 15]. Recently, more effective and sustainable methods have been employed for the extraction of bioactive compounds from rosemary [16]. High temperatures during processing result in the loss of bioactivity of the extracts due to the fact that rosemary contains mostly thermolabile compounds. Therefore, low temperatures during extraction are favorable [17]. The quest for natural alternatives with a wide range of applications fuels the extraction of rosemary's bioactive compounds, which are a fundamental component of scientific research [14, 15, 18].
The extraction of bioactive components from rosemary has recently moved toward more sustainable and efficient methods [16]. Maceration, decoction, conventional reflux, and Soxhlet extraction are some examples of traditional extraction methods that have been widely used [19]. Maceration and Soxhlet extraction are two conventional methods of extraction that were commonly used in the past for preparing extracts of nonvolatile compounds. However, owing to the many disadvantages associated with these methods, such as the long time required for extraction, thermal degradation of thermolabile compounds, high energy and solvent requirements, contamination of the extract, and loss of solute, these methods are rarely employed in an industrial environment.
Currently, a number of new and promising eco‐friendly bioactive extract production methods from rosemary are under investigation. Supercritical fluid extraction (SFE), pressurized liquid extraction (PLE), ultrasound‐assisted extraction (UAE), and microwave‐assisted extraction (MAE) are the most investigated techniques for the production of rosemary extracts. When choosing a method, cost, time, and the stability of the targeted compounds must be considered. This pairing of efficacy and history places a high premium on modifying traditional extraction methods to modern applications in the search for bioactive constituents from rosemary [20, 21]. These strategies seek to develop new applications across a variety of food storage and pharmaceutical industries, based on the full utilization of the bioactive compounds in rosemary. Identifying optimum extraction methods is in line with the general green biorefinery idea, which focuses on sustainability and resource effectiveness [22].
6.1. Ultrasound‐ And Microwave‐Assisted Extraction
Currently, two of the most frequently employed “green” techniques for accelerating the extraction process are MAE and UAE. Various methods have been proposed until now to efficiently extract the phenolic fraction from rosemary leaves. Bellumori M and co‐workers investigated the efficiency and selectivity of these methods in extracting specific components from dried rosemary leaves using food‐grade solvents. UAE was performed using a probe system equipped with a titanium horn operating at 19.5 kHz (140 W). MAE was performed at 100°C using a closed multimode reactor under an N2 atmosphere (20 bar). After dissolving each extract in a fixed volume of solvent, solutions were analyzed directly using complementary time‐of‐flight (TOF) and high‐performance liquid chromatography‐UV‐diode array detector‐mass spectrometry (HPLC–DAD–MS) methods. MAE and UAE in ethanol and acetone resulted in significant improvements in the yields of phenol, by more than three times compared to more conventional solid‐liquid extraction methods [23].
6.2. Supercritical Fluid Extraction
There are a number of ways that CO2 extraction can be used to recover oil esters from plant material. One is to combine plant oil, water, and crushed raw material in a specific ratio to create a mixed feed liquid. The plant extract oil is then created by subjecting the mixed feed liquid to supercritical CO2 extraction to yield extract liquor, which is then separated further from the water by oil in a high‐speed centrifuge. To yield an expanded liquid, another technique is milling of the material, ethanol addition as an assisted solvent, and subsequent expansion of the treated sample under CO2 pressure. This technique improves the oil extraction yield and reduces the extraction pressure by soaking the substance in liquid CO2 [24]. Benefits of this approach include lower energy requirements, selectivity, and faster extraction procedures [25, 26, 27]. The potential of SFE to produce bioactive compounds has also been studied extensively [28, 29].
A two‐step sequential SFE procedure was developed by del Pilar Sanchez Camargo et al. to produce rosemary extracts that are substantially enriched in carnosic acid and carnosol. The less active interfering fractions, such as waxes and oleoresins, were eliminated during the first extraction step using supercritical CO2 at 300 bar and 40°C after 60 min. The recovery of CA (403.04 mg/g) and CS (44.56 mg/g) was improved after 120 min during the second extraction step with CO2 and 7% ethanol as a modifier at 150 bar and 40°C. Compared to single‐step SFE, the proposed two‐stage SFE also decreased the overall extraction time from 300 to 180 min. It was also noted that the incorporation of a 7% ethanol modifier increased the yield of rosemary SFE extract from 3.1 to 6.5% at 100°C and 100–150 bar. The authors concluded that SFE of CO2 with a 7% ethanol modifier can be an effective method for extracting moderately polar compounds such as CA and CS in rosemary [28].
6.3. Pressurized Liquid Extraction
The most applied method to extract bioactive phenolic compounds from S. rosmarinus is PLE, followed by SFE. In this respect, Herrero et al. reported that PLE at high temperatures of 200°C with water and ethanol as the preferred solvents resulted in rosemary extracts with high yields of about 40% and high antioxidative activity with an EC50 of 8.8 µg/mL after 20 min [30].
Under these conditions, carnosic acid (52.87 mg/g) was extracted effectively. Moreover, PLE with ethanol turned out to be more successful for less polar molecules, such as CA and CS. Finally, Vázquez et al. determined that the yields of CA and CS, amounting to 161.49 and 13.64 mg/g, respectively, were twice as high in PLE extracts obtained with hexane at 100°C and 100 bar after 20 min compared to SFE extracts obtained at the same temperature and using pure supercritical CO2 after 5 h at 200°C and 300 bar [31].
7. Biosynthetic Pathway
The terpene precursors dimethylallyl diphosphate (DMAPP, C5) and isopentenyl diphosphate (IPP, C5) can be synthesized separately in the cytosol and plastid through separate pathways. The prenyltransferases mediate the formation of the terpene precursors with IPP and DMAPP. The formation of geranyl diphosphate (GPP) from geranyl diphosphate synthase (GPS) mediates the synthesis of monoterpenes (C10), farnesyl diphosphate (FPP) from farnesyl diphosphate synthase (FPS) mediates the synthesis of sesquiterpenes (C15) and triterpenes (C30), while geranylgeranyl diphosphate (GGPP) from geranylgeranyl diphosphate synthase (GGPS) mediates the synthesis of diterpenes (C20) and tetraterpenes (C40) [32, 33].
GGPP is the main C20 precursor for the biosynthesis of abietane diterpenoids in S. rosmarinus and acts as an important intermediate molecule responsible for the formation of unique diterpene skeletons. The general isoprenoid precursors, IPP and DMAPP, are involved in consecutive condensation reactions catalyzed by prenyltransferases to generate the C20 prenyl diphosphate precursor GGPP through the methylerythritol phosphate (MEP) pathway within the plastids [34]. The terpene synthases copalyl diphosphate synthase (CPS) and miltiradiene synthase (MiS), which resemble kaurene synthase, catalyze the initial committed steps of abietane diterpenoid biosynthesis. The enzyme CPS converts GGPP into copalyl diphosphate, and the latter is converted to miltiradiene by MiS. Miltiradiene spontaneously undergoes an aromatization or oxidation process, resulting in abietatriene, which acts as the immediate precursor for phenolic abietane diterpenoids in rosemary and its related species from the Lamiaceae family. The aromatic diterpene called abietatriene is then modified by cytochrome P450 monooxygenase enzymes, mostly from the CYP76 family. These enzymes, called CYP76AH, carry out a series of oxidations of abietatriene, yielding ferruginol and 11‐hydroxyferruginol. Enzymes CYP76AK contribute to further oxidation at the C20 site, catalyzing 11‐hydroxyferruginol transformation via intermediate steps that lead to the formation of carnosic acid, a major phenolic abietane diterpenoid in rosemary leaves [35, 36, 37]. Due to oxidation, hydroxylation, methylation, and rearrangement reactions, carnosic acid acts as an important biosynthetic center from which numerous structurally related abietane diterpenoids originate. Carnosol is one such abietane, synthesized by the spontaneous oxidation of carnosic acid, and it significantly increases the antioxidant properties of rosemary extracts. Thus, the GGPP route that links isoprenoid metabolism with biosynthesis of pharmaceutically valuable abietanes such as ferruginol, carnosic acid, carnosol, rosmanol, and other diterpenoid derivatives of diterpenes can be considered the fundamental biosynthetic pathway for the generation of rosemary abietane diterpenoids (Figure 4).
FIGURE 4.

Biosynthesis of abietane‐type diterpenoids from geranylgeranyl diphosphate (GGPP).
8. Diterpenoids’ Structural Occurrence and Degradation Properties
In 1969, after synthesizing fichtelite, a fossil resin hydrocarbon from abietic acid (7,13‐abietadien‐18‐oic acid), Burgstahler created a semi‐systematic system for naming and numbering the diterpenoid family [38]. Substances with a 20‐carbon core structure are called aromatic abietanes [3]. A‐ring carbons typically do not provide functional groups to aromatic abietanes. Most of the B‐ and C‐ring carbons have various levels of oxidation. Usually, double bonds occur on ring C, with amounts ranging from three (abietatrienes) to four (abietatetraenes). The aromatic abietane group contains many different chemical structures derived from dehydroabietic acid. We can categorize them by the type of carbocyclic framework and the number of double bonds. These include tricyclic abietatrienes, abietatriene lactones (compounds with three double bonds and a lactone ring), and abietatetraenes (compounds with four double bonds) (Figure 5).
FIGURE 5.

Chemical structures of abietane–type diterpenoids found in S. rosmarinus.
CA, a derivative of pisiferic acid, contains a C20 carboxylic acid. It is found in the well‐known Lamiaceae herb, rosemary (S. rosmarinus). The o‐diphenol structure of carnosic acid is easily oxidized and has strong antioxidant properties [36]. Researchers have investigated several biological activities of CA. For example, CA stimulates T98G human glioblastoma cells to produce nerve growth factor, suggesting potential as a treatment for Alzheimer's disease [39]. CA also prevents excitotoxicity and oxidative stress in neurons. It protects the brain from middle cerebral artery ischemia/reperfusion and increases reduced glutathione levels in vivo [40]. Studies show that CA has anticancer effects [17]. For example, in combination with turmeric or curcumin, CA strongly inhibits the growth of ER‐negative human breast cancer cells and induces G1 cell cycle arrest [41].
The main constituents of rosemary from the Lamiaceae family are lactones. These compounds are part of a group called abietatriene lactones. The other key component of these plants is that CA is oxidized to produce them. Carnosol has hydroxy groups on carbons C11 and C12, and a keto group on carbon C20, along with an aromatic C ring. This abietane shows antibacterial effects against oral bacteria that lead to tooth decay, as well as anti‐HIV activity (IC50 8.0 µM) [42].
CS and CA suppress the formation of pro‐inflammatory leukotrienes in whole human polymorphonuclear leukocytes (PMNL) (IC50 7.0 µM [CS], 15–20 µM [CA]). Anti‐inflammatory activity of CS and CA has also been investigated in vivo. Since CS has the potential to inhibit DNA damage and tumor growth in the rat mammary gland, it can be employed as a chemopreventive drug for breast cancer [43]. More oxidized diterpenes, such as 11,12‐di‐O‐methylrosmanol, isorosmanol, and rosmadial, are synthesized from rosemary leaves by the antioxidant activity of carnosic acid [8, 44]. The free radical scavenging ability of the molecule is reduced by the O‐methylation of one of the two hydroxyl groups at C11 and C12 [45].
8.1. Degradation Study of Abietane Diterpenoids
Carnosic acid was detected as the major phenolic diterpene in rosemary leaves, while rosmanol, epirosmanol, and 7‐methyl‐epirosmanol were only present in small amounts. This indicates that lactone‐structured phenolic diterpenes may form during extraction when the extract is exposed to air [46]. According to Wenkert et al., benzoquinone changes to semiquinone, which then transforms into δ‐ and γ‐lactones [47]. The production of carnosol led to a drop in the concentration of carnosic acid, which then decomposed to produce γ‐lactones, rosmanol, epirosmanol, and 7‐methyl‐epirosmanol [46]. The γ‐lactones, rosmanol, epirosmanol, and 7‐methyl‐epirosmanol come from carnosol instead of the quinone and semiquinone intermediates of carnosic acid (Figure 6) [48].
FIGURE 6.

Degradation of carnosic acid to different modified diterpenoids.
9. Structure‐Activity Relationship
The abietane diterpenoids isolated from S. rosmarinus are carnosic acid, carnosol, rosmanol, epirosmanol, isorosmanol, and galdosol. Some structural features of the abietane framework play a key role in influencing the biological activities of these compounds, including antioxidant, antibacterial, anti‐inflammatory, and anticancer activities.
Similar to carnosic acid and its derivatives, having a hydroxyl group at positions C11 and C12, and a carboxyl group at position C20 gives rise to antitumor compounds. Compounds containing catechol, such as carnosol and its derivatives, with a diosphenol moiety in addition to the B ring, possess this property.
The association of the diterpenes and their ability to scavenge free radicals is the key aspect in the antioxidant activity of rosemary. According to research, the antioxidant properties of the diterpenes in rosemary are described. The conjugation of the three rings and the aromatic ring (C11‐C12) in the catechol group is the key element of diterpene structure. The catechol group is responsible for scavenging the radical electron formed as a result of oxidation. The presence of three rings gives the backbone, which helps in delocalization of the charge. This conjugation is further strengthened by the presence of the carboxylic moiety (in the case of carnosic acid). The lipophilic nature of abietane diterpenoids such as carnosic acid and its antioxidant activity suggest that its functioning is similar to α‐tocopherol in scavenging free radicals formed as a result of the photosynthetic activity of chloroplasts [13].
10. Semisynthesis of Abietane Diterpenes
Most abietane diterpenoids are naturally rare; this is why much attention has been paid to their semisynthesis from readily available precursors such as carnosic acid and carnosol. These naturally occurring diterpenes are very suitable starting materials for creating structurally diverse abietane derivatives that show higher biological activity.
For instance, carnosic acid is capable of undergoing various chemical modifications due to the presence of the carboxylic acid functionality on C20, phenolic hydroxyl functionalities on C11 and C12, and an active benzylic position at C7.
Carnosol (2) can be quantitatively prepared from an acetone solution of carnosic acid (1) in the presence of molecular oxygen. Rosmanol (3) was the only compound formed from the reaction of the acetone solution of carnosol (2) with aqueous sodium bicarbonate at room temperature to introduce the oxygen function at C7 (Figure 7). Moreover, the catechol function was oxidized in situ to rosmaquinone (6) when the above reaction was carried out with a mixture of sodium bicarbonate and hydrogen peroxide (Figure 7). The semisynthetic rosmanol (3) and rosmaquinone (6) showed identical physical and spectral properties to the natural compounds as reported in the literature. The 7‐methoxyrosmanol (5) was the main product obtained from the reaction of carnosol (2) with sodium methoxide in methanol, while 7‐ethoxyrosmanol (4) was the main product obtained from the reaction of carnosol with sodium ethoxide in ethanol (Figure 7).
FIGURE 7.

Modification of carnosic acid into derivatives using various reagents.
Pyridinium chlorochromate oxidized rosmanol (3), which was isolated from carnosol (2), yielding two compounds. Upon separation by column chromatography, these compounds were characterized as rosmaquinone (6) and galdosol (7), respectively (Figure 8). Through the less hindered si face of the carbonyl group by attacking C7 with a hydride, the reduction of galdosol by sodium borohydride in methanol resulted in the formation of epirosmanol (8) (Figure 8) as expected. In all aspects, these compounds' spectroscopic and physical properties corresponded to those of actual data and natural samples [49].
FIGURE 8.

Chemical transformation of rosmanol into epi‐rosmanol.
By introducing certain modifications at the C‐ring and C20 position, a research group produced various carnosic acid derivatives (8a–8f) (Figure 9). The antiproliferative activity of these compounds towards the P388 murine leukaemia cell line was evaluated. Amongst these two compounds, 8a and 8b, with IC50 values of 0.27 and 0.22 µg/mL, respectively, having an ester functional group at C20 and an o‐quinone or o‐quinone equivalent system in the C‐ring, proved to be highly active. The results obtained were much more encouraging than those obtained with carnosic acid (IC50 = 1.2 µg/mL). The low effectiveness of derivative 8c (IC50 = 0.6 µg/mL), which differs from the other derivatives in only one feature, implies that the presence of an o‐quinone group (or its analogues) in the C‐ring is necessary for the antiproliferative effect. This can be seen in the case of derivatives 8d and 8e, where the IC50 of derivative 8e (0.94 µg/mL) became lower than that of derivative 8d (1.9 µg/mL) because of the o‐quinone group added to derivative 8e [50].
FIGURE 9.

Murine leukaemia cell line P388 was employed to determine the IC50 values of derivatives 8a–8f of Carnosic acid. Cells were treated with increasing concentrations of drugs for 48 h, after which IC50 values were determined by MTT assay.
With its potent antioxidant, anti‐inflammatory, and anticancer activities, carnosic acid has become a principal scaffold in recent semisynthetic studies in medicinal chemistry. The C20 carboxylic acid, catechol hydroxyls at C11/C12, and aromatic C‐ring have all undergone various modifications to generate several derivatives. These modifications include esterification, amidation, carbamate formation, acetylation, oxidation, and nitrogen substitution. These modifications were aimed at maintaining the unique abietane skeleton intact while improving lipophilicity, metabolic stability, cellular uptake, and selectivity toward targets [51, 52, 53, 54, 55].
In general, the semisynthesis of rosemary abietane diterpenoids has advanced beyond the synthesis of naturally occurring minor metabolites to the rational production of derivatives that are optimized pharmaceutically. The chemical diversity of rosemary diterpenoids has expanded greatly through these semisynthesis techniques, making the abietane scaffold a desirable starting point for future drug discovery.
11. Pharmacokinetics of Abietane Diterpenoids From S. rosmarinus
The pharmacokinetic characteristics of rosemary abietane diterpenoids have mainly been studied using carnosic acid and its metabolite carnosol in rat models. Carnosic acid was administered intragastrically (90 mg/kg), showing a time of maximum concentration (Tmax) of 125.6 min, maximum plasma concentration (Cmax) of 126 µM, area under the curve (AUC0–t) of 21 755.3 mg/L/min, and oral bioavailability of 65.09% in male Sprague–Dawley rats [56]. In a second study that used a lower dose of carnosic acid (64.3 mg/kg) administered intragastrically, a Tmax of 136.6 min, Cmax of 105 µM, AUC0–t of 7.05 mg/mL/min, and oral bioavailability of 40.1% were observed [10]. The third study used rosemary extract standardized to 40% carnosic acid content (571 mg/kg rosemary extract containing 230 mg/kg carnosic acid) in female Zucker rats. A total of 26 diterpenes, including the primary metabolites, were identified, with the most abundant being carnosol, carnosic acid, rosmariquinone, carnosic acid 12‐methylether, carnosic acid glucuronide, and carnosol glucuronide. In this study, the Tmax of carnosol is 13.3 min, its Cmax is 18.2 µM, and its AUCall is 137.4 µM h, while that of carnosic acid is 24 min, 26.6, and 178.8 µM [9]. Compared to other phytochemicals from the diet, carnosic acid is known for having a good oral bioavailability (40%–65%) that enables it to produce pharmacological effects in cellular models.
12. Pharmacological Activity of Abietane Diterpenoids
The secondary metabolites present in rosemary, such as carnosol, carnosic acid, etc., have drawn interest for their possible therapeutic use [57]. Abietane diterpenoids show a range of interesting biological effects. Below is a list of the most important diterpenoids and their characteristics. Here, we provide a detailed overview of some biological activities of abietane diterpenoids based on various studies.
12.1. Antioxidant Activity
The abietane diterpenoids in S. rosmarinus, including carnosic acid, carnosol, and rosmanol, contribute mainly to its antioxidant effect through their ability to scavenge free radicals and inhibit oxidative propagation reactions. This is achieved due to the phenolic and quinoid nature of these compounds, which allows them to act as chain‐breaking antioxidants [58, 59]. In addition, these molecules can chelate transition‐metal ions, especially Fe2+, thereby minimizing the formation of reactive oxygen species (ROS). In contrast to synthetic antioxidants such as butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT), and propyl gallate, carnosic acid and carnosol exhibit a stronger inhibitory effect on membrane lipid peroxidation and serve as potent scavengers of peroxyl radicals.
It is reported that rosmanol shows very high antioxidant activity; in both linoleic acid and lard, it is about four times more efficient than certain commercially available antioxidants. Also, 90% of the total antioxidant power of rosemary extract is due to carnosic acid and carnosol, which act effectively as scavengers of hydroxyl and peroxyl radicals, preventing lipid peroxidation in biological membranes. Thus, the use of abietane diterpenoids from rosemary as natural antioxidants is medically significant [60, 61].
12.2. Antimicrobial Activity
Abietane diterpenes are key phytochemical components of S. rosmarinus that contribute significantly to its antimicrobial effect. Research into these compounds has identified several specific diterpenoids with varying degrees of antibacterial potency against both Gram‐positive and Gram‐negative bacteria [62, 63].
Studies have identified various abietane‐type diterpenoids in rosemary extracts. 12‐methoxy‐carnosic acid exhibits significant inhibitory effects against several strains. It has been shown to have a Minimum Inhibitory Concentration (MIC) of 8 µg/ml against Staphylococcus aureus, 16 µg/ml against Bacillus subtilis, and 32 µg/ml against Pseudomonas aeruginosa. Galdosol, another potent abietane diterpene, shows strong activity with MIC values of 16 µg/ml against S. aureus and 32 µg/ml against both B. subtilis and P. aeruginosa [62]. Moreover, carnosic acid and carnosol are frequently credited with antibacterial effects against pathogens such as S. aureus, Escherichia coli, etc [64]. Utilizing these naturally occurring diterpenes may offer a therapeutic alternative to synthetic antibiotics, potentially addressing issues related to increasing bacterial resistance [63].
12.3. Anti‐Inflammatory Activity
The activity of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐KB) was constrained by rosemary and its hexane fractions through inhibiting the phosphorylation of mitogen‐activated protein kinases (MAPKs). As a result, there was a decrease in the synthesis of two key enzymes, cyclooxygenase‐2 (COX‐2) and inducible nitric oxide synthase (iNOS), which are involved in inflammatory processes through the generation of NO and PGE2, respectively [65]. This was consistently seen in another study that used extracts of fresh rosemary leaves and their purified components, carnosol and CA, on mouse skin (Figure 10) [66].
FIGURE 10.

The effect of Carnosic acid and Carnosol on inflammation and neuroprotection.
12.4. Neuroprotective Activity
Rosemary produces a profound therapeutic effect on mood, anxiety, pain, learning, and sleep. Nervous system disorders are characterized by abnormalities in the central or peripheral nervous system structure or function. Trauma, infections, metabolic diseases, or hereditary conditions may trigger these diseases. In conventional medicine, rosemary has been utilized to cure numerous diseases, including dysmenorrhea, epilepsy, rheumatic pain, spasms, hysteria, and physical and mental fatigue (Figure 10).
The Nuclear factor erythroid 2‐related factor 2/Kelch‐like ECH‐associated protein 1 (Nrf2/Keap1) signaling pathway acts as the primary process that mediates the neuroprotective effects of carnosic acid and carnosol. The abietane diterpenoids help Nrf2 dissociate from Keap1 when there is oxidative stress, allowing Nrf2 to enter the nucleus and bind to antioxidant response elements (AREs). As a result, the intracellular reactive oxygen species (ROS) levels inside the cell are decreased, and the redox balance is restored due to the increased synthesis of protective enzymes, including heme oxygenase‐1 (HO‐1), superoxide dismutase (SOD), and catalase (CAT).
The resultant reduction in oxidative stress leads to the prevention of neuroinflammation and neuronal damage by inhibiting the generation of inflammatory mediators such as NF‐KB, Tumor Necrosis Factor‐alpha (TNF‐α), Interleukin‐1 beta (IL‐1β), Interleukin‐6 (IL‐6), iNOS, and COX‐2. Carnosic acid and carnosol protect against neurodegeneration through the synergistic regulation of oxidative and inflammatory signaling pathways.
Parkinson's disease is an age‐associated disorder that leads to the degeneration of certain areas of the brain. It is well‐known for producing tremors, slow movements, and balance problems. The chief constituent of S. rosmarinus, carnosol, possesses highly active anti‐inflammatory and antioxidant properties. A study revealed that carnosol safeguarded the cultured dopaminergic neuronal cell line (SN4741) against rotenone‐induced neurotoxicity. Furthermore, carnosol safeguarded cultured dopaminergic neuronal cells (SN4741) from dieldrin‐induced neurotoxicity. The neuroprotective actions of carnosol are attributed to the Raf‐MEK‐ERK1/2 pathways (Raf‐mitogen‐activated protein kinase (MEK)‐extracellular signal‐regulated kinase (ERK)1/2 signaling pathway), which block cell death in cells of dopamine neurons and increase tyrosine hydroxylase expression. As an antioxidant, carnosol can be a potential therapy for Parkinson's disease symptoms as well as the dopamine system [67, 68].
12.5. Anticancer Activity
The uncontrolled growth of abnormal cells that possess the ability to invade and kill normal cells in the body is referred to as cancer. The second leading cause of death globally is cancer. Nonetheless, due to advances in the detection of cancer, treatment of cancer, and prevention of cancer, survival rates for many types of cancer are increasing. Rosemary extracts have been shown to possess a wide variety of anticancer properties against many forms of cancer. Nevertheless, in vitro and animal experiments have demonstrated the anticancer activities of rosemary, some of which are attributed to its primary components, including carnosic acid and carnosol. Ethanolic rosemary extract was able to prevent DNA damage in CaCo‐2 colon carcinoma cells caused by hydrogen peroxide and visible light‐excited methylene blue. Based on its free radical scavenging ability, the use of rosemary in colon cancer prevention was established. Methanolic, ethanolic, and supercritical rosemary extracts were employed in a study to establish the antiproliferative activity of rosemary on breast cancer cells. The most active compound in this activity was carnosic acid in many of these studies. From the many extraction methods, rosemary's bioactive compounds were best extracted with supercritical fluids compared to methanolic extraction, and these extracts reliably proved to be most inhibitory to cell proliferation [69].
The anticancer activity of bioactive components of Salvia rosmarinus, carnosic acid and carnosol, is characterized by a multifaceted mechanism of action that targets various stages of tumor development and progression (Figure 11).
FIGURE 11.

Mechanism of anticancer activity of abietane diterpenes.
The general descriptive mechanism of action includes the following processes:
12.5.1. Induction of Apoptosis
S. rosmarinus compounds trigger programmed cell death through both the intrinsic (mitochondrial) and extrinsic (death receptor) pathways [70]. This process involves:
12.5.1.1. Modulation of Pro/Anti‐Apoptotic Proteins
Upregulation of pro‐apoptotic markers such as Bcl‐2‐associated X protein (Bax) and p53, and the downregulation of anti‐apoptotic proteins like β‐cell lymphoma‐2 (Bcl‐2), survivin, and mouse double minute 2 (Mdm2) [71].
12.5.1.2. Caspase Activation
S. rosmarinus compounds lead to the activation of the caspase cascade (e.g., caspases‐3,7 and 9) and the subsequent cleavage of Poly(ADP‐ribose) polymerase (PARP), which are hallmarks of irreversible cell death [72].
12.5.2. Cell‐Cycle Arrest
The bioactive compounds of S. rosmarinus inhibit tumor cell proliferation by arresting the cell cycle at various phases, most commonly G0/G1, S, or G2/M phases, depending on the cancer type. This is achieved by:
Inhibiting cyclins and cyclin‐dependent kinases (CDKs): Reducing the levels of cyclins and CDKs is necessary for phase transition.
Upregulating inhibitors: Increasing the expression of CDK inhibitors such as p21WAF1 and p27KIP1 [73].
12.5.3. Modulation of Key Signaling Pathways
S. rosmarinus diterpenes disrupt several signaling cascades essential for cancer cell survival and growth.
Phosphoinositide 3‐kinase (PI3K)/protein kinase B (AKT)/ mechanistic target of rapamycin (mTOR) pathway: Inhibition of this pathway leads to decreased protein synthesis and survival signals.
MAPK pathways: S. rosmarinus modulates extracellular signal‐regulated kinase (ERK1/2), c‐Jun N‐terminal kinase (JNK), and p38 pathways, which are critical for mediating apoptosis and stress responses [74, 75].
Janus kinase (JAK)/ Signal Transducer and Activator of Transcription (STAT) Pathway: Compounds like CA and CS inhibit STAT3 and STAT5 phosphorylation, suppressing the expression of genes linked to proliferation and survival [70].
NF‐KB pathway: Suppression of NF‐KB activation reduces inflammation and the expression of survival factors [76].
12.5.4. Generation of Oxidative Stress(ROS)
While S. rosmarinus acts as an antioxidant in normal cells by activating the Nrf2 pathway, it often functions as a pro‐oxidant in cancer cells. The generation of ROS in tumor cells leads to the following:
12.5.5. Inhibition of Metastasis, Invasion, and Angiogenesis
S. rosmarinus impairs the ability of cancer cells to spread and form new blood vessels:
Anti‐invasive effects: Downregulation of proteases like matrix metalloproteinases (MMP‐2, MMP‐9) and urokinase Plasminogen Activator (uPA), while increasing tissue inhibitors of metalloproteinases (TIMPs) [75, 79].
Epithelial mesenchymal transition (EMT) reversal: Upregulation of the epithelial marker E‐cadherin and downregulation of mesenchymal markers like N‐cadherin and vimentin, effectively blocking the epithelial‐to‐mesenchymal transition [80].
12.5.6. Sensitization and Synergy
S. rosmarinus can overcome chemoresistance by inhibiting drug efflux transporters such as P‐glycoprotein (P‐gp), thereby increasing the efficacy of chemotherapeutic agents like cisplatin, 5‐fluorouracil, and doxorubicin. It also exhibits synergistic effects when combined with various drugs and natural products [77, 81].
13. Safety Profile and Toxicity Effects of Abietane Diterpenoids
The use of rosemary extract as a potent, safe natural antioxidant for food preservation has been authorized by the European Union [82]. While the topical and oral use of rosemary is generally considered safe, it is imperative to note that herbal medicines can also produce negative reactions. Rashes and allergies could result from rosemary formulations used by some individuals. Moreover, some groups, such as those with kidney or liver ailments, and pregnant and lactating women, should be careful when using rosemary [7, 83].
Although abietane diterpenoids from S. rosmarinus, such as carnosic acid, carnosol, and rosmanol, possess remarkable pharmacological features, their safety profile should be considered while developing their use in medicine. In vitro studies using differentiated and undifferentiated HepaRG cells demonstrated that carnosic acid, carnosol, and rosmanol proved to possess relatively lower toxicity towards differentiated cells owing to their higher detoxifying potential. Rosmanol induced the most substantial metabolic change, followed by carnosol and carnosic acid [84].
The acute and 30‐day oral toxicity of carnosic acid has been studied in an in vivo experiment. In the acute toxicity test, the median lethal dose (LD50) of carnosic acid in mice was found to be 7100 mg/kg. Histopathology alteration was seen in the heart, liver, and kidneys of surviving mice after administering a single dose of carnosic acid. In the subchronic toxicity test, administration of carnosic acid in rats for 30 days led to a slight reduction in weight gain pattern, but not considerably in comparison with the control group. High and moderate doses of carnosic acid produced elevated levels of aminotransferase (AST) but low levels of total serum protein in the blood biochemical examination. According to histopathology analysis, rats treated with high doses of carnosic acid had minor pathological abnormalities in their liver, kidney, and heart [85].
However, based on the currently available information, it seems that the abietane diterpenoids found in S. rosmarinus have a good safety margin even when used in therapeutic dosages. However, more detailed studies regarding their chronic toxicity, reproductive safety, pharmacokinetics, and clinical tests in humans should be carried out.
14. Future Perspective
The usefulness of abietane‐type diterpenoids isolated from S. rosmarinus as natural medicines is reflected by the growing evidence supporting their therapeutic potential. In view of proving efficacy and safety in humans, future studies should focus on translating the accumulated body of data from in vitro experiments and animal models to clinical trials in humans. Given the ability of carnosic acid and carnosol to cross the blood‐brain barrier and affect oxidative and inflammatory pathways via activation of the Nrf2/Keap1 pathway, their use for neuroprotection deserves special attention. Valuable diterpenoids such as carnosic acid, carnosol, rosmanol, and epirosmanol can be produced sustainably owing to advances in metabolic engineering, synthetic biology, and plant biotechnology.
In addition, the stability, bioavailability, and tissue‐specific targeting can be increased through the use of liposomal delivery systems, nanoformulations, and other drug‐delivery techniques. In addition, more potent derivatives, which will demonstrate superior antitumor, anti‐inflammatory, antibacterial, and neuroprotective effects, can be developed through further study of structure‐activity relationships and semi‐synthetic modifications. Besides studying the currently available diterpenoids, there are other types of diterpenoids and their activities that need to be explored. Additionally, the entire use of S. rosmarinus will eventually become a focus of research.
15. Conclusion
The abietane‐type diterpenoids, which comprise carnosic acid, carnosol, rosmanol, epirosmanol, isorosmanol, and galdosol found in S. rosmarinus, have been established to be a highly diverse group of natural compounds with great pharmaceutical value. The occurrence, biochemical pathway through geranylgeranyl diphosphate, diversity in structure, metabolism, semi‐synthesis, pharmacology, pharmacokinetics, and several biological functions of these compounds have been covered in this review. Of these compounds, carnosic acid is one of the most important compounds that plays the role of a pharmacologically active compound and also forms various oxidized abietane derivatives with numerous properties.
Although semisynthesis strategies have proven that targeted modifications of the abietane skeleton could lead to the enhancement of their biological activities, the latest advancements in green extraction approaches have increased the efficiency in isolating such bioactive diterpenoids. The problem of transforming the rosemary abietane diterpenoids into clinically viable drugs remains unresolved due to poor standardization, lack of human trials, and insufficient knowledge of their mechanisms of action despite positive preclinical findings. In any case, it should be mentioned that the plant S. rosmarinus represents an environment‐friendly source of biologically active abietane diterpenoids, and future investigations could be expected.
Author Contributions
Rida Siddiqui: conceptualization, methodology, formal analysis, data curation, writing – original draft. Vipin Singh: writing – original draft; Kapil Dev: conceptualization, methodology, resources, supervision, writing – original draft, writing – review and editing.
Funding
The authors received funding support from the Council of Scientific and Industrial Research (CSIR) Aroma Mission (HCP‐0007 and MMP‐025304) and CSIR‐FTT020502/CRM1 projects.
Conflicts of Interest
The authors declare no conflicts of interest.
Acknowledgments
We acknowledge the encouragement and support received from the Director, CSIR‐CIMAP. We also acknowledge ULIP (MLP‐2610) for the necessary infrastructure and facilities support. RS is thankful to CSIR‐FTT020502/CRM1 and ICMR‐EMDR/SG/12/2025‐6613 for providing the fellowship. We are thankful to CSIR‐Aroma Mission (HCP‐0007 and MMP‐025304) for providing the financial assistance. This manuscript's CSIR‐CIMAP communication number is CIMAP/PUB/2026/32.
Data Availability Statement
Data sharing is not applicable to this article, as no datasets were generated or analyzed during the current study.
References
- 1. Akaberi M., Mehri S., and Iranshahi M., “Multiple Pro‐apoptotic Targets of Abietane Diterpenoids from Salvia Species,” Fitoterapia 100 (2015): 118–132, 10.1016/j.fitote.2014.11.008. [DOI] [PubMed] [Google Scholar]
- 2. Will M. and Claßen‐Bockhoff R., “Time to Split Salvia s.l. (Lamiaceae) – New Insights From Old World Salvia Phylogeny,” Molecular Phylogenetics and Evolution 109 (2017): 33–58, 10.1016/j.ympev.2016.12.041. [DOI] [PubMed] [Google Scholar]
- 3. González M. A., “Aromatic Abietane Diterpenoids: Their Biological Activity and Synthesis,” Natural Product Reports 32, no. 5 (2015): 684–704, 10.1039/c4np00110a. [DOI] [PubMed] [Google Scholar]
- 4. González M. A., “Aromatic Abietane Diterpenoids: Total Syntheses and Synthetic Studies,” Tetrahedron 71, no. 13 (2015): 1883–1908, 10.1016/j.tet.2015.01.058. [DOI] [Google Scholar]
- 5. Zhou T., Wang J., Lin Z., et al., “Abietane Diterpenoids With Anti‐Neuroinflammation Activity From Rosmarinus officinalis ,” Fitoterapia 174 (2024): 105866, 10.1016/j.fitote.2024.105866. [DOI] [PubMed] [Google Scholar]
- 6. Wu Y.‐B., Ni Z.‐Y., Shi Q.‐W., et al., “Constituents From Salvia Species and Their Biological Activities,” Chemical Reviews 112, no. 11 (2012): 5967–6026, 10.1021/cr200058f. [DOI] [PubMed] [Google Scholar]
- 7. Ribeiro‐Santos R., Carvalho‐Costa D., Cavaleiro C., et al., “A Novel Insight on an Ancient Aromatic Plant: The Rosemary (Rosmarinus officinalis L.),” Trends in Food Science & Technology 45, no. 2 (2015): 355–368, 10.1016/j.tifs.2015.07.015. [DOI] [Google Scholar]
- 8. Munné‐Bosch S., Alegre L., and Schwarz K., “The Formation of Phenolic Diterpenes in Rosmarinus officinalis L. Under Mediterranean Climate,” European Food Research and Technology 210, no. 4 (2000): 263–267, 10.1007/s002179900108. [DOI] [Google Scholar]
- 9. Vaquero M. R., Villalba R. G., Larrosa M., et al., “Bioavailability of the Major Bioactive Diterpenoids in a Rosemary Extract: Metabolic Profile in the Intestine, Liver, Plasma, and Brain of Zucker Rats,” Molecular Nutrition & Food Research 57, no. 10 (2013): 1834–1846, 10.1002/mnfr.201300052. [DOI] [PubMed] [Google Scholar]
- 10. Doolaege E. H. A., Raes K., De Vos F., Verhé R., and De Smet S., “Absorption, Distribution and Elimination of Carnosic Acid, a Natural Antioxidant from Rosmarinus officinalis, in Rats,” Plant Foods for Human Nutrition 66, no. 2 (2011): 196–202, 10.1007/s11130-011-0233-5. [DOI] [PubMed] [Google Scholar]
- 11. Song Y., Yan H., Chen J., Wang Y., Jiang Y., and Tu P., “Characterization of in Vitro and in Vivo Metabolites of Carnosic Acid, a Natural Antioxidant, by High Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry,” Journal of Pharmaceutical and Biomedical Analysis 89 (2014): 183–196, 10.1016/j.jpba.2013.11.001. [DOI] [PubMed] [Google Scholar]
- 12. Teja Y. S. C., Jyothika L. S., Vasavi N., Reddy K. S. S. H., and Sudheer A., “Exploring the Therapeutic Potential of Rosemary: An In‐Depth Review of Its Pharmacological Properties,” Asian Journal of Advances in Medical Science 6, no. 1 (2024): 19–31, https://hal.science/hal‐05103649. [Google Scholar]
- 13. Munné‐Bosch S. and Alegre L., “Subcellular Compartmentation of the Diterpene Carnosic Acid and Its Derivatives in the Leaves of Rosemary,” Plant Physiology 125, no. 2 (2001): 1094–1102, 10.1104/pp.125.2.1094. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Lešnik S., Furlan V., and Bren U., “Rosemary (Rosmarinus officinalis L.): Extraction Techniques, Analytical Methods and Health‐promoting Biological Effects,” Phytochemistry Reviews 20, no. 6 (2021): 1273–1328, 10.1007/s11101-021-09745-5. [DOI] [Google Scholar]
- 15. Ali A., Chua B. L., and Chow Y. H., “An Insight into the Extraction and Fractionation Technologies of the Essential Oils and Bioactive Compounds in Rosmarinus officinalis L.: Past, Present and Future,” TrAC Trends in Analytical Chemistry 118 (2019): 338–351, 10.1016/j.trac.2019.05.040. [DOI] [Google Scholar]
- 16. Giacometti J., Kovačević D. B., Putnik P., et al., “Extraction of Bioactive Compounds and Essential Oils from Mediterranean Herbs by Conventional and Green Innovative Techniques: A Review,” Food Research International 113 (2018): 245–262, 10.1016/j.foodres.2018.06.036. [DOI] [PubMed] [Google Scholar]
- 17. Erkan N., “Stability of some Phenolic Antioxidants and Linoleic Acid in Solution Under Microwave and Conventional Heating Conditions,” Focus Modern Food Industries 2 (2013): 179–184, https://www.airitilibrary.com/Article/Detail?DocID=P20150410004‐201311‐201508310024‐201508310024‐179‐184. [Google Scholar]
- 18. Aziz E., Batool R., Akhtar W., et al., “Rosemary Species: A Review of Phytochemicals, Bioactivities and Industrial Applications,” South African Journal of Botany 151 (2022): 3–18, 10.1016/j.sajb.2021.09.026. [DOI] [Google Scholar]
- 19. Quitério E., Grosso C., Ferraz R., Delerue‐Matos C., and Soares C., “A Critical Comparison of the Advanced Extraction Techniques Applied to Obtain Health‐Promoting Compounds From Seaweeds,” Marine Drugs 20, no. 11 (2022): 677, 10.3390/md20110677. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Brückner K., Božić D., Manzano D., et al., “Characterization of Two Genes for the Biosynthesis of Abietane‐Type Diterpenes in Rosemary (Rosmarinus officinalis) Glandular Trichomes,” Phytochemistry 101 (2014): 52–64, 10.1016/j.phytochem.2014.01.021. [DOI] [PubMed] [Google Scholar]
- 21. Armenta S., Garrigues S., Esteve‐Turrillas F. A., and de la Guardia M., “Green Extraction Techniques in Green Analytical Chemistry,” TrAC Trends in Analytical Chemistry 116 (2019): 248–253, 10.1016/j.trac.2019.03.016. [DOI] [Google Scholar]
- 22. González‐Minero F. J., Bravo‐Díaz L., and Ayala‐Gómez A., “ Rosmarinus officinalis L.(Rosemary): an Ancient Plant With Uses in Personal Healthcare and Cosmetics,” Cosmetics 7, no. 4 (2020): 77, 10.3390/cosmetics7040077. [DOI] [Google Scholar]
- 23. Bellumori M., Innocenti M., Binello A., Boffa L., Mulinacci N., and Cravotto G., “Selective Recovery of Rosmarinic and Carnosic Acids from Rosemary Leaves Under Ultrasound‐and Microwave‐Assisted Extraction Procedures,” Comptes Rendus Chimie 19, no. 6 (2016): 699–706, 10.1016/j.crci.2015.12.013. [DOI] [Google Scholar]
- 24. Bimakr M., Rahman R. A., Ganjloo A., Taip F. S., Salleh L. M., and Sarker M. Z. I., “Optimization of Supercritical Carbon Dioxide Extraction of Bioactive Flavonoid Compounds From Spearmint (Mentha spicata L.) Leaves by Using Response Surface Methodology,” Food and Bioprocess Technology 5, no. 3 (2012): 912–920, 10.1007/s11947-010-0504-4. [DOI] [Google Scholar]
- 25. Lefebvre T., Destandau E., West C., and Lesellier E., “Supercritical Fluid Chromatography Development of a Predictive Analytical Tool to Selectively Extract Bioactive Compounds by Supercritical Fluid Extraction and Pressurised Liquid Extraction,” Journal of Chromatography A 1632 (2020): 461582, 10.1016/j.chroma.2020.461582. [DOI] [PubMed] [Google Scholar]
- 26. Patil P. D., Patil S. P., Kelkar R. K., Patil N. P., Pise P. V., and Nadar S. S., “Enzyme‐assisted Supercritical Fluid Extraction: An Integral Approach to Extract Bioactive Compounds,” Trends in Food Science & Technology 116 (2021): 357–369, 10.1016/j.tifs.2021.07.032. [DOI] [Google Scholar]
- 27. Da Silva R. P., Rocha‐Santos T. A., and Duarte A. C., “Supercritical Fluid Extraction of Bioactive Compounds,” TrAC Trends in Analytical Chemistry 76 (2016): 40–51, 10.1016/j.trac.2015.11.013. [DOI] [Google Scholar]
- 28. Sánchez‐Camargo A. D. P., Valdés A., Sullini G., et al., “Two‐step Sequential Supercritical Fluid Extracts From Rosemary With Enhanced Anti‐Proliferative Activity,” Journal of Functional Foods 11 (2014): 293–303, 10.1016/j.jff.2014.10.014. [DOI] [Google Scholar]
- 29. Singh S., Verma D. K., Thakur M., et al., “Supercritical Fluid Extraction (SCFE) as Green Extraction Technology for High‐Value Metabolites of Algae, Its Potential Trends in Food and Human Health,” Food Research International 150 (2021): 110746, 10.1016/j.foodres.2021.110746. [DOI] [PubMed] [Google Scholar]
- 30. Herrero M., Plaza M., Cifuentes A., and Ibáñez E., “Green Processes for the Extraction of Bioactives From Rosemary: Chemical and Functional Characterization via Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry and In‐Vitro Assays,” Journal of Chromatography A 1217, no. 16 (2010): 2512–2520, 10.1016/j.chroma.2009.11.032. [DOI] [PubMed] [Google Scholar]
- 31. Vázquez E., García‐Risco M. R., Jaime L., Reglero G., and Fornari T., “Simultaneous Extraction of Rosemary and Spinach Leaves and Its Effect on the Antioxidant Activity of Products,” Journal of Supercritical Fluids 82 (2013): 138–145, 10.1016/j.supflu.2013.07.004. [DOI] [Google Scholar]
- 32. Bach T. J., “Some New Aspects of Isoprenoid Biosynthesis in Plants—A Review,” Lipids 30, no. 3 (1995): 191–202, 10.1007/BF02537822. [DOI] [PubMed] [Google Scholar]
- 33. Luthra R., Luthra P. M., and Kumar S., “Redefined Role of Mevalonate–Isoprenoid Pathway in Terpenoid Biosynthesis in Higher Plants,” Current Science 76, no. 2 (1999): 133–135, https://www.jstor.org/stable/24101222. [Google Scholar]
- 34. Vranová E., Coman D., and Gruissem W., “Network Analysis of the MVA and MEP Pathways for Isoprenoid Synthesis,” Annual Review of Plant Biology 64 (2013): 665–700, 10.1146/annurev-arplant-050312-120116. [DOI] [PubMed] [Google Scholar]
- 35. Ignea C., Athanasakoglou A., Ioannou E., et al., “Carnosic Acid Biosynthesis Elucidated by a Synthetic Biology Platform,” Proceedings of the National Academy of Sciences 113, no. 13 (2016): 3681–3686, 10.1073/pnas.1523787113. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Božić D., Papaefthimiou D., Brückner K., et al., “Towards Elucidating Carnosic Acid Biosynthesis in Lamiaceae: Functional Characterization of the Three First Steps of the Pathway in Salvia fruticosa and Rosmarinus officinalis ,” PLoS ONE 10, no. 5 (2015): e0124106, 10.1371/journal.pone.0124106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Scheler U., Brandt W., Porzel A., et al., “Elucidation of the Biosynthesis of Carnosic Acid and Its Reconstitution in Yeast,” Nature Communications 7, no. 1 (2016): 2942, 10.1038/ncomms12942. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Burgstahler A. W. and Marx J. N., “Synthesis of Fichtelite and Related Derivatives of abietane,” Journal of Organic Chemistry 34, no. 6 (1969): 1562–1566, 10.1021/jo01258a006. [DOI] [Google Scholar]
- 39. Kosaka K. and Yokoi T., “Carnosic Acid, a Component of Rosemary (Rosmarinus officinalis L.), Promotes Synthesis of Nerve Growth Factor in T98G Human Glioblastoma Cells,” Biological and Pharmaceutical Bulletin 26, no. 11 (2003): 1620–1622, 10.1248/bpb.26.1620. [DOI] [PubMed] [Google Scholar]
- 40. Satoh T., Kosaka K., Itoh K., et al., “Carnosic Acid, a Catechol‐Type Electrophilic Compound, Protects Neurons both In Vitro and In Vivo Through Activation of the Keap1/Nrf2 Pathway via S‐ Alkylation of Targeted Cysteines on Keap1,” Journal of Neurochemistry 104, no. 4 (2008): 1116–1131, 10.1111/j.1471-4159.2007.05039.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Einbond L. S., Wu H.‐A., Kashiwazaki R., et al., “Carnosic Acid Inhibits the Growth of ER‐Negative Human Breast Cancer Cells and Synergizes With Curcumin,” Fitoterapia 83, no. 7 (2012): 1160–1168, 10.1016/j.fitote.2012.07.006. [DOI] [PubMed] [Google Scholar]
- 42. Aruoma O. I., Spencer J. P. E., Rossi R., et al., “An Evaluation of the Antioxidant and Antiviral Action of Extracts of Rosemary and Provençal Herbs,” Food and Chemical Toxicology 34, no. 5 (1996): 449–456, 10.1016/0278-6915(96)00004-X. [DOI] [PubMed] [Google Scholar]
- 43. Singletary K., MacDonald C., and Wallig M., “Inhibition by Rosemary and Carnosol of 7, 12‐dimethylbenz [a] Anthracene (DMBA)‐induced Rat Mammary Tumorigenesis and In Vivo DMBA‐DNA Adduct Formation,” Cancer Letters 104, no. 1 (1996): 43–48, 10.1016/0304-3835(96)04227-9. [DOI] [PubMed] [Google Scholar]
- 44. Munné‐Bosch S., Mueller M., Schwarz K., and Alegre L., “Diterpenes and Antioxidative Protection in Drought‐Stressed Salvia officinalis Plants,” Journal of Plant Physiology 158, no. 11 (2001): 1431–1437, 10.1078/0176-1617-00578. [DOI] [Google Scholar]
- 45. Brieskorn C. and Dömling H., “Natural and Synthetic Derivatives of Carnosol Acid. Mitteilungen,” Deutsche Pharmazeutische Gesellschaft 39, no. 9 (1969): 641–649, https://pubmed.ncbi.nlm.nih.gov/5395340/. [PubMed] [Google Scholar]
- 46. Schwarz K. and Ternes W., “Antioxidative Constituents of Rosmarinus officinalis and Salvia officinalis: II. Isolation of Carnosic Acid and Formation of Other Phenolic Diterpenes,” Zeitschrift für Lebensmittel‐Untersuchung und Forschung 195, no. 2 (1992): 99–103, 10.1007/BF01201766. [DOI] [PubMed] [Google Scholar]
- 47. Wenkert E., Fuchs A., and McChesney J. D., “Chemical Artifacts From the Family Labiatae,” Journal of Organic Chemistry 30, no. 9 (1965): 2931–2934, 10.1021/jo01020a012. [DOI] [Google Scholar]
- 48. Zhang Y., Smuts J. P., Dodbiba E., Rangarajan R., Lang J. C., and Armstrong D. W., “Degradation Study of Carnosic Acid, Carnosol, Rosmarinic Acid, and Rosemary Extract (Rosmarinus officinalis L.) Assessed Using HPLC,” Journal of Agricultural and Food Chemistry 60, no. 36 (2012): 9305–9314, 10.1021/jf302179c. [DOI] [PubMed] [Google Scholar]
- 49. Marrero J. G., Andrés L. S., and Luis J. G., “Semisynthesis of Rosmanol and Its Derivatives. Easy Access to Abietatriene Diterpenes Isolated from the Genus Salvia with Biological Activities,” Journal of Natural Products 65, no. 7 (2002): 986–989, 10.1021/np010565o. [DOI] [PubMed] [Google Scholar]
- 50. Aoyagi Y., Takahashi Y., Satake Y., et al., “Cytotoxicity of Abietane Diterpenoids from Perovskia Abrotanoides and of Their Semisynthetic Analogues,” Bioorganic & Medicinal Chemistry 14, no. 15 (2006): 5285–5291, 10.1016/j.bmc.2006.03.047. [DOI] [PubMed] [Google Scholar]
- 51. Pertino M. W., Theoduloz C., Rodríguez J. A., Yáñez T., Lazo V., and Schmeda‐Hirschmann G., “Gastroprotective Effect of Carnosic Acid γ‐lactone Derivatives,” Journal of Natural Products 73, no. 4 (2010): 639–643, 10.1021/np900822x. [DOI] [PubMed] [Google Scholar]
- 52. Han S., Li X., Xia Y., et al., “Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural‐Product‐Derived Inhibitors and Their Activity in Pancreatic Cancer Cells,” Journal of Medicinal Chemistry 62, no. 23 (2019): 10867–10896, 10.1021/acs.jmedchem.9b01405. [DOI] [PubMed] [Google Scholar]
- 53. Moura S. P. S. P., Marín S., Rufino I., Guedes R. C., Cascante M., and Salvador J. A. R., “Design, Synthesis, and Biological Evaluation of Novel Urea‐Containing Carnosic Acid Derivatives with Anticancer Activity,” International Journal of Molecular Sciences 25, no. 24 (2024): 13332, 10.3390/ijms252413332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Moura S. P. S. P., Cascante M., Rufino I., Guedes R. C., Marin S., and Salvador J. A. R., “Synthesis and Biological Evaluation of Novel Carnosic Acid Derivatives with Anticancer Activity,” RSC Advances 15, no. 44 (2025): 36861–36878, 10.1039/d5ra02441b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Pertino M., Theoduloz C., Butassi E., Zacchino S., and Schmeda‐Hirschmann G., “Synthesis, Antiproliferative and Antifungal Activities of 1, 2, 3‐Triazole‐Substituted Carnosic Acid and Carnosol Derivatives,” Molecules 20, no. 5 (2015): 8666–8686, 10.3390/molecules20058666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Yan H., Wang L., Li X., et al., “High‐Performance Liquid Chromatography Method for Determination of Carnosic Acid in Rat Plasma and Its Application to Pharmacokinetic Study,” Biomedical Chromatography 23, no. 7 (2009): 776–781, 10.1002/bmc.1184. [DOI] [PubMed] [Google Scholar]
- 57. de Macedo L. M., Santos É. M., Militão L., et al., “Rosemary (Rosmarinus officinalis L., syn Salvia rosmarinus Spenn.) and Its Topical Applications: A Review,” Plants 9, no. 5 (2020): 651, 10.3390/plants9050651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Houlihan C. M., Ho C. T., and Chang S. S., “The Structure of Rosmariquinone — A New Antioxidant Isolated from Rosmarinus officinalis L,” Journal of the American Oil Chemists' Society 62, no. 1 (1985): 96–98, 10.1007/BF02541500. [DOI] [Google Scholar]
- 59. Wu J. W., Lee M.‐H., Ho C.‐T., and Chang S. S., “Elucidation of the Chemical Structures of Natural Antioxidants Isolated from Rosemary,” Journal of the American Oil Chemists' Society 59, no. 8 (1982): 339–345, 10.1007/BF02541016. [DOI] [Google Scholar]
- 60. Chen C., Pearson A., and Gray J., “Effects of Synthetic Antioxidants (BHA, BHT and PG) on the Mutagenicity of IQ‐Like Compounds,” Food Chemistry 43, no. 3 (1992): 177–183, 10.1016/0308-8146(92)90170-7. [DOI] [Google Scholar]
- 61. Aruoma O. I., “Antioxidant Actions of Plant Foods: Use of Oxidative DNA Damage as a Tool for Studying Antioxidant Efficacy,” Free Radical Research 30, no. 6 (1999): 419–427, 10.1080/10715769900300461. [DOI] [PubMed] [Google Scholar]
- 62. Xu Q. J., Liu J. C., Xu J., Wang X., Shang X. Y., and Zi J., “Antimicrobial Diterpenoids From Rosmarinus officinalis ,” Steroids 217 (2025): 109589, 10.1016/j.steroids.2025.109589. [DOI] [PubMed] [Google Scholar]
- 63. Sinha M., Kumari D., Mishra U., Fatima B., and Singh A., “Phytochemical Screening and Antimicrobial Study of Rosmarinus officinalis ,” Journal of Pharmacognosy and Phytochemistry 14, no. 1 (2025): 144–151, 10.22271/phyto.2025.v14.i1b.15232. [DOI] [Google Scholar]
- 64. Sienkiewicz M., Łysakowska M., Pastuszka M., Bienias W., and Kowalczyk E., “The Potential of Use Basil and Rosemary Essential Oils as Effective Antibacterial Agents,” Molecules 18, no. 8 (2013): 9334–9351, 10.3390/molecules18089334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Yu M.‐H., Choi J.‐H., Chae I.‐G., et al., “Suppression of LPS‐induced Inflammatory Activities by Rosmarinus officinalis L,” Food Chemistry 136, no. 2 (2013): 1047–1054, 10.1016/j.foodchem.2012.08.085. [DOI] [PubMed] [Google Scholar]
- 66. Mengoni E. S., Vichera G., Rigano L. A., et al., “Suppression of COX‐2, IL‐1β and TNF‐α Expression and Leukocyte Infiltration in Inflamed Skin by Bioactive Compounds From Rosmarinus officinalis L,” Fitoterapia 82, no. 3 (2011): 414–421, 10.1016/j.fitote.2010.11.023. [DOI] [PubMed] [Google Scholar]
- 67. Kim S.‐J., Kim J.‐S., Cho H.‐S., et al., “Carnosol, a Component of Rosemary (Rosmarinus officinalis L.) Protects Nigral Dopaminergic Neuronal Cells,” Neuroreport 17, no. 16 (2006): 1729–1733, 10.1097/01.wnr.0000239951.14954.10. [DOI] [PubMed] [Google Scholar]
- 68. Park J. A., Kim S., Lee S.‐Y., et al., “Beneficial Effects of Carnosic Acid on Dieldrin‐Induced Dopaminergic Neuronal Cell Death,” Neuroreport 19, no. 13 (2008): 1301–1304, 10.1097/WNR.0b013e32830abc1f. [DOI] [PubMed] [Google Scholar]
- 69. Bouammali H., Zraibi L., Ziani I., et al., “Rosemary as a Potential Source of Natural Antioxidants and Anticancer Agents: A Molecular Docking Study,” Plants 13, no. 1 (2024): 89, 10.3390/plants13010089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Park J. E., Park B., Chae I. G., et al., “Carnosic Acid Induces Apoptosis Through Inactivation of Src/STAT3 Signaling Pathway in Human Renal Carcinoma Caki Cells,” Oncology Reports 35, no. 5 (2016): 2723–2732, 10.3892/or.2016.4642. [DOI] [PubMed] [Google Scholar]
- 71. Kim D.‐H., Park K.‐W., Chae I. G., et al., “Carnosic Acid Inhibits STAT3 Signaling and Induces Apoptosis Through Generation of ROS in Human Colon Cancer HCT116 Cells,” Molecular Carcinogenesis 55, no. 6 (2016): 1096–1110, 10.1002/mc.22353. [DOI] [PubMed] [Google Scholar]
- 72. Su K., Wang C.‐F., Zhang Y., Cai Y.‐J., Zhang Y.‐Y., and Zhao Q., “The Inhibitory Effects of Carnosic Acid on Cervical Cancer Cells Growth by Promoting Apoptosis via ROS‐Regulated Signaling Pathway,” Biomedicine & Pharmacotherapy 82 (2016): 180–191, 10.1016/j.biopha.2016.04.056. [DOI] [PubMed] [Google Scholar]
- 73. Borhan A., Bagherlou A., and Ghayour M. B., “Evaluating the Anticancer Effects of Carnosic Acid against Breast Cancer: An In Vitro Investigation,” Tissue and Cell 93 (2025): 102718, 10.1016/j.tice.2024.102718. [DOI] [PubMed] [Google Scholar]
- 74. El‐Huneidi W., Bajbouj K., Muhammad J. S., et al., “Carnosic Acid Induces Apoptosis and Inhibits Akt/mTOR Signaling in Human Gastric Cancer Cell Lines,” Pharmaceuticals 14, no. 3 (2021): 230, 10.3390/ph14030230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Zhao L., Zhang J., Fan Y., and Li Y., “Antiproliferative Activity of Carnosic Acid Is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3‐kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway,” Medical Science Monitor 25 (2019): 7864–7871, 10.12659/MSM.917735. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Zhang X., Chen Y., Cai G., Li X., and Wang D., “Carnosic Acid Induces Apoptosis of Hepatocellular Carcinoma Cells via ROS‐Mediated Mitochondrial Pathway,” Chemico‐Biological Interactions 277 (2017): 91–100, 10.1016/j.cbi.2017.09.005. [DOI] [PubMed] [Google Scholar]
- 77. Nabekura T., Yamaki T., Hiroi T., Ueno K., and Kitagawa S., “Inhibition of Anticancer Drug Efflux Transporter P‐Glycoprotein by Rosemary Phytochemicals,” Pharmacological Research 61, no. 3 (2010): 259–263, 10.1016/j.phrs.2009.11.010. [DOI] [PubMed] [Google Scholar]
- 78. Han L., Li L., and Wu G., “Induction of Ferroptosis by Carnosic Acid‐Mediated Inactivation of Nrf2/HO‐1 Potentiates Cisplatin Responsiveness in OSCC Cells,” Molecular and Cellular Probes 64 (2022): 101821, 10.1016/j.mcp.2022.101821. [DOI] [PubMed] [Google Scholar]
- 79. Barni M. V., Carlini M. J., Cafferata E. G., Puricelli L., and Moreno S., “Carnosic Acid Inhibits the Proliferation and Migration Capacity of Human Colorectal Cancer Cells,” Oncology Reports 27, no. 4 (2012): 1041–1048, 10.3892/or.2012.1630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80. Park S., Song H., Sung M.‐K., Kang Y.‐H., Lee K., and Park J., “Carnosic Acid Inhibits the Epithelial‐Mesenchymal Transition in B16F10 Melanoma Cells: A Possible Mechanism for the Inhibition of Cell Migration,” International Journal of Molecular Sciences 15, no. 7 (2014): 12698–12713, 10.3390/ijms150712698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81. Tai J., Cheung S., Wu M., and Hasman D., “Antiproliferation Effect of Rosemary (Rosmarinus officinalis) on Human Ovarian Cancer Cells In Vitro,” Phytomedicine 19, no. 5 (2012): 436–443, 10.1016/j.phymed.2011.12.012. [DOI] [PubMed] [Google Scholar]
- 82. Younes M., Aggett P., Aguilar F., et al., “Refined Exposure Assessment of Extracts of Rosemary (E 392) From Its Use as Food Additive,” EFSA Journal 16, no. 8 (2018): e05373, 10.2903/j.efsa.2018.5373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83. Miroddi M., Calapai G., Isola S., Minciullo P. L., and Gangemi S., “ Rosmarinus officinalis L. as Cause of Contact Dermatitis,” Allergologia et Immunopathologia 42, no. 6 (2014): 616–619, 10.1016/j.aller.2013.04.006. [DOI] [PubMed] [Google Scholar]
- 84. Acunha T., García‐Cañas V., Valdés A., Cifuentes A., and Simó C., “Metabolomics Study of Early Metabolic Changes in Hepatic HepaRG Cells in Response to Rosemary Diterpenes Exposure,” Analytica Chimica Acta 1037 (2018): 140–151, 10.1016/j.aca.2017.12.006. [DOI] [PubMed] [Google Scholar]
- 85. Wang Q. L., Li H., Li X. X., et al., “Acute and 30‐Day Oral Toxicity Studies of Administered Carnosic Acid,” Food and Chemical Toxicology 50, no. 12 (2012): 4348–4355, 10.1016/j.fct.2012.08.057. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article, as no datasets were generated or analyzed during the current study.
